ATC代碼C02(抗高血壓藥)是解剖學治療學及化學分類系統的一個藥物分組,這是由世界衛生組織藥物統計方法整合中心(The WHO Collaborating Centre for Drug Statistics Methodology)所制定的藥品及其它醫用產品的官方分類系統。分組C02是C心血管系統的一部分。[1]
Quick Facts ATC代碼, C 心血管系統 ...
Close
獸用代碼(ATCvet碼)可以在人用ATC代碼前加Q字母:QC02等[2]。
國家ATC分類可能包括列表中沒有的其它分類,列表為世界衛生組織(WHO)版本。
- C02AA01 瑞西那明(Rescinnamine)
- C02AA02 利舍平(Reserpine)
- C02AA03 蛇根木生物鹼複方(Combinations of rauwolfia alkaloids)
- C02AA04 蛇根木生物鹼,全根(Rauwolfia alkaloids, whole root)
- C02AA05 地舍平(Deserpidine)
- C02AA06 美索舍平(Methoserpidine)
- C02AA07 比他舍平(Bietaserpine)
- C02AA52 利舍平複方(Reserpine, combinations)
- C02AA53 蛇根木生物鹼複方(Combinations of rauwolfia alkoloids, combinations)
- C02AA57 比他舍平複方(Bietaserpine, combinations)
- C02AB01 甲基左旋多巴(Methyldopa (levorotatory))
- C02AB02 甲基多巴(消旋)(Methyldopa (racemic))
- C02AC01 可樂定(Clonidine)
- C02AC02 胍法辛(Guanfacine)
- C02AC04 托洛尼定(Tolonidine)
- C02AC05 莫索尼定(Moxonidine)
- C02AC06 利美尼定(Rilmenidine)
- C02BA01 樟磺咪芬(Trimetaphan)
- C02BB01 美卡拉明(Mecamylamine)
- C02CA01 哌唑嗪(Prazosin)
- C02CA02 吲哚拉明(Indoramin)
- C02CA03 曲馬唑嗪(Trimazosin)
- C02CA04 多沙唑嗪(Doxazosin)
- C02CA06 烏拉地爾(Urapidil)
- C02CC01 倍他尼定(Betanidine)
- C02CC02 胍乙啶(Guanethidine)
- C02CC03 胍生(Guanoxan)
- C02CC04 異喹胍(Debrisoquine)
- C02CC05 胍氯酚(Guanoclor)
- C02CC06 胍那佐定(Guanazodine)
- C02CC07 胍諾沙苄(Guanoxabenz)
- C02DB01 雙肼屈嗪(Dihydralazine)
- C02DB02 肼屈嗪(Hydralazine)
- C02DB03 恩屈嗪(Endralazine)
- C02DB04 卡屈嗪(Cadralazine)
- C02DD01 硝普鹽(Nitroprusside)
- C02KX01 波生坦(Bosentan)
- C02KX02 安利生坦(Ambrisentan)
- C02KX03 西他生坦(Sitaxentan)
- C02LA01 利舍平和利尿藥(Reserpine and diuretics)
- C02LA02 瑞西那明和利尿藥(Rescinnamine and diuretics)
- C02LA03 地舍平和利尿藥(Deserpidine and diuretics)
- C02LA04 美索舍平和利尿藥(Methoserpidine and diuretics)
- C02LA07 比他舍平和利尿藥(Bietaserpine and diuretics)
- C02LA08 蛇根木生物鹼,全根和利尿藥(Rauwolfia alkaloids, whole root and diuretics)
- C02LA09 昔洛舍平和利尿藥(Syrosingopine and diuretics)
- C02LA50 蛇根木生物鹼和利尿藥的複方,含其它複方(Combinations of rauwolfia alkaloids and diuretics including other combinations)
- C02LA51 利舍平和利尿藥以及其它藥物的複方(Reserpine and diuretics, combinations with other drugs)
- C02LA52 瑞西那明和利尿藥以及其它藥物的複方(Rescinnamine and diuretics, combinations with other drugs)
- C02LA71 利舍平和利尿藥以及與安定藥的複方(Reserpine and diuretics, combinations with psycholeptics)
- C02LB01 甲基左旋多巴和利尿藥(Methyldopa (levorotatory) and diuretics)
- C02LC01 可樂定和利尿藥(Clonidine and diuretics)
- C02LC05 莫索尼定和利尿藥(Moxonidine and diuretics)
- C02LC51 可樂定和利尿藥以及其它藥物的複方(Clonidine and diuretics, combinations with other drugs)
- C02LE01 哌唑嗪和利尿藥(Prazosin and diuretics)
- C02LF01 胍乙啶和利尿藥(Guanethidine and diuretics)
- C02LG01 雙肼屈嗪和利尿藥(Dihydralazine and diuretics)
- C02LG02 肼屈嗪和利尿藥(Hydralazine and diuretics)
- C02LG03 吡考屈嗪和利尿藥(Picodralazine and diuretics)
- C02LG51 雙肼屈嗪和利尿藥以及其它藥物的複方(Dihydralazine and diuretics, combinations with other drugs)
- C02LG73 吡考屈嗪和利尿藥以及安定藥的複方(Picodralazine and diuretics, combinations with psycholeptics)
- C02LK01 藜蘆和利尿藥(Veratrum and diuretics)
- C02LL01 帕吉林和利尿藥(Pargyline and diuretics)
- C02LX01 吡那地爾和利尿藥(Pinacidil and diuretics)
ATC Index. WHO Collaborating Centre for Drug Statistics Methodology.
ATCvet Index. WHO Collaborating Centre for Drug Statistics Methodology.